These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 11093363)
21. An assessment of iloperidone for the treatment of schizophrenia. Jain KK Expert Opin Investig Drugs; 2000 Dec; 9(12):2935-43. PubMed ID: 11093363 [TBL] [Abstract][Full Text] [Related]
22. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market? Albers LJ; Musenga A; Raggi MA Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919 [TBL] [Abstract][Full Text] [Related]
23. New atypical antipsychotics for schizophrenia: iloperidone. Caccia S; Pasina L; Nobili A Drug Des Devel Ther; 2010 Feb; 4():33-48. PubMed ID: 20368905 [TBL] [Abstract][Full Text] [Related]
24. Iloperidone for the treatment of schizophrenia. Marino J; Caballero J Ann Pharmacother; 2010 May; 44(5):863-70. PubMed ID: 20388862 [TBL] [Abstract][Full Text] [Related]
25. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic. Citrome L Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791 [TBL] [Abstract][Full Text] [Related]
26. Iloperidone: A new drug for the treatment of schizophrenia. Arif SA; Mitchell MM Am J Health Syst Pharm; 2011 Feb; 68(4):301-8. PubMed ID: 21289324 [TBL] [Abstract][Full Text] [Related]
28. Iloperidone: a new option for the treatment of schizophrenia. Cutler AJ Expert Rev Neurother; 2009 Dec; 9(12):1727-41. PubMed ID: 19951132 [TBL] [Abstract][Full Text] [Related]
29. Iloperidone for the treatment of schizophrenia. Bishop JR; Bishop DL Drugs Today (Barc); 2010 Aug; 46(8):567-79. PubMed ID: 20830317 [TBL] [Abstract][Full Text] [Related]
30. Iloperidone for the management of adults with schizophrenia. Crabtree BL; Montgomery J Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386 [TBL] [Abstract][Full Text] [Related]
32. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion. Citrome L Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370 [TBL] [Abstract][Full Text] [Related]
33. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Bobo WV Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794 [TBL] [Abstract][Full Text] [Related]
34. Risperidone: review of its pharmacology and therapeutic use in schizophrenia. Gupta S; Black DW; Smith DA Ann Clin Psychiatry; 1994 Sep; 6(3):173-80. PubMed ID: 7533585 [TBL] [Abstract][Full Text] [Related]
35. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Grant S; Fitton A Drugs; 1994 Aug; 48(2):253-73. PubMed ID: 7527327 [TBL] [Abstract][Full Text] [Related]
36. A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors. He H; Richardson JS Int Clin Psychopharmacol; 1995 Mar; 10(1):19-30. PubMed ID: 7542676 [TBL] [Abstract][Full Text] [Related]
37. An update on the efficacy and safety of iloperidone as a schizophrenia therapy. Nair A; Salem A; Asamoah AL; Gosal R; Grossberg GT Expert Opin Pharmacother; 2020 Oct; 21(15):1793-1798. PubMed ID: 32735148 [TBL] [Abstract][Full Text] [Related]
38. Safety profile of iloperidone in the treatment of schizophrenia. Dargani NV; Malhotra AK Expert Opin Drug Saf; 2014 Feb; 13(2):241-6. PubMed ID: 24206391 [TBL] [Abstract][Full Text] [Related]
39. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Bishara D; Taylor D Drugs; 2008; 68(16):2269-92. PubMed ID: 18973393 [TBL] [Abstract][Full Text] [Related]